| Literature DB >> 30709440 |
Jeffrey K Mito1, Devarati Mitra2, Leona A Doyle3.
Abstract
Approximately half of all cancer patients receive radiation therapy as part of their oncologic treatment. Radiation-associated sarcomas occur in fewer than 1% of patients who receive radiation therapy but account for up to 5% of all sarcomas. As the use of radiation has increased in the past few decades and overall oncologic outcomes are improving, the incidence of radiation-associated sarcomas is also expected to increase. Historically, radiation-associated sarcomas have been associated with poor outcomes but recent data suggest the prognosis is improving. Distinguishing the sarcoma from the primary malignancy is a major diagnostic criterion.Entities:
Keywords: Immunohistochemistry; Molecular genetics; Radiation; Radiation-associated; Sarcoma; Secondary malignancy; Soft tissue; Tumor
Mesh:
Year: 2018 PMID: 30709440 DOI: 10.1016/j.path.2018.10.010
Source DB: PubMed Journal: Surg Pathol Clin ISSN: 1875-9157